·Î»ç¸£Åº(Losartan) ½ÃÀå : ÀûÀÀÁõº°, ³óµµº°, Á¦Ç° À¯Çüº°, ¿¬·ÉÃþº°, ¼ºº°, À¯Åë ä³Îº°, Çüź°, °ø±Þ¿øº°, Áö¿ªº°
Losartan Market, By indication, By Strength, By Product Type, By Age Group, By Gender, By Distribution Channel, By Form, By Source, By Geography
»óǰÄÚµå : 1767670
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,338,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,859,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,085,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

·Î»ç¸£Åº(Losartan0 ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 16¾ï 8,000¸¸ ´Þ·¯, 2032³â¿¡´Â 22¾ï 3,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 4.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÐ¼® ¹üÀ§ ºÐ¼® »ó¼¼
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 16¾ï 8,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) 4.10% ¿¹Ãø ±Ý¾×(2032³â) 22¾ï 3,000¸¸ ´Þ·¯

¼¼°è ·Î»çÆ®¶õ ½ÃÀåÀº Àü ¼¼°è °íÇ÷¾Ð ¹× ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ÈûÀÔ¾î ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¾ÈÁö¿ÀÅٽŠII ¼ö¿ëü ±æÇ×Á¦ÀÎ ·Î»çÆ®¶õÀº °íÇ÷¾Ð, ½ÉºÎÀü, ´ç´¢º´¼º ½ÅÁõ Ä¡·áÁ¦·Î ³Î¸® ó¹æµÇ°í ÀÖ½À´Ï´Ù. °Ç°­ÇÑ »ýȰ½À°ü°ú È¿°úÀûÀÎ Ç÷¾Ð °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå È®´ë¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ·Î»çÆ®¶õÀÇ Á¦³×¸¯ ÀǾàǰÀ» ½±°Ô ±¸ÇÒ ¼ö ÀÖ°í °¡°ÝÀÌ Àú·ÅÇØÁø °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. È¿°úÀûÀÎ Ç×°íÇ÷¾ÐÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ·Î»çÆ®¶õ ½ÃÀåÀº ÇâÈÄ ¸î ³â µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è ·Î»çÆ®¶õ ½ÃÀåÀº ¸î °¡Áö ÁÖ¿ä ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ¹× ±âȸ¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº °íÇ÷¾Ð°ú ½ÉºÎÀü ¹× ³úÁ¹Áß°ú °°Àº °ü·Ã ½ÉÇ÷°ü°è ÁúȯÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ÁÂ½Ä »ýȰ, ºñ¸¸, ³ôÀº ½ºÆ®·¹½º ¼öÁØÀ» Ư¡À¸·Î ÇÏ´Â °Ç°­¿¡ ÇØ·Î¿î »ýȰ ½À°üÀº °íÇ÷¾Ð ¹ß»ý·üÀ» Å©°Ô Áõ°¡½ÃÄ×½À´Ï´Ù. ¶ÇÇÑ È¿°úÀûÀÎ Ç÷¾Ð °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Àú·ÅÇÑ °¡°ÝÀÇ ·Î»çÆ®¶õ Á¦³×¸¯ ÀǾàǰÀÇ °¡¿ë¼ºÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ´ëü Ç×°íÇ÷¾ÐÁ¦ÀÇ Á¸Àç¿Í ·Î»çÆ®¶õ »ç¿ë¿¡ µû¸¥ ÀáÀçÀû ºÎÀÛ¿ë µî ½ÃÀå¿¡´Â ÀÏÁ¤ÇÑ ¾ïÁ¦¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºê·£µå ·Î»çÆ®¶õ Á¦Ç°ÀÇ Æ¯Çã ¸¸·á·Î ÀÎÇØ Á¦³×¸¯ ¾÷ü¿ÍÀÇ °æÀïÀÌ Ä¡¿­ÇØÁ® ÁÖ¿ä ¾÷üµé ½ÃÀå Á¡À¯À²¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾î·Á¿ò¿¡µµ ºÒ±¸Çϰí, ½ÃÀåÀº »õ·Î¿î ¾à¹° Àü´Þ ½Ã½ºÅÛ °³¹ß, ·Î»çÆ®¶õÀÇ Ä¡·á ¿ëµµ È®´ë, °íÇ÷¾Ð À¯º´·üÀÌ ³ôÀº ½ÅÈï °æÁ¦±¹¿¡¼­ÀÇ ¹Ì°³Ã´ ÀáÀç·Â µî À¯¸ÁÇÑ ¼ºÀå ±âȸ¸¦ Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾à»ç °£ Àü·«Àû Á¦ÈÞ ¹× ÇÕº´À¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È ±â¼ú Çõ½ÅÀÌ ÃËÁøµÇ°í ½ÃÀå ¹üÀ§°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» º¸°í¼­ÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå ºÐ¼® ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : ÀûÀÀÁõº°(2020-2032³â)

Á¦5Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : ³óµµº°(2020-2032³â)

Á¦6Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : Á¦Ç° À¯Çüº°(2020-2032³â)

Á¦7Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : ¿¬·ÉÃþº°(2020-2032³â)

Á¦8Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : ¼ºº°(2020-2032³â)

Á¦9Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : À¯Åë ä³Îº°(2020-2032³â)

Á¦10Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : Çüź°(2020-2032³â)

Á¦11Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : °ø±Þ¿øº°(2020-2032³â)

Á¦12Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : Áö¿ªº°(2020-2032³â)

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È

Á¦15Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Losartan Market is estimated to be valued at USD 1.68 Bn in 2025 and is expected to reach USD 2.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.68 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.10% 2032 Value Projection: USD 2.23 Bn

The global Losartan market has witnessed significant growth in recent years, driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Losartan, an angiotensin II receptor antagonist, is widely prescribed for the treatment of high blood pressure, heart failure, and diabetic nephropathy. The market's expansion is further fueled by unhealthy lifestyles and rising awareness about the importance of effective blood pressure management. Moreover, the availability of generic Losartan products has increased their accessibility and affordability, contributing to their widespread adoption. As the demand for efficient antihypertensive medications continues to rise, the global Losartan market is poised for substantial growth in the coming years.

Market Dynamics

The global Losartan market is influenced by several key drivers, restraints, and opportunities. The primary driver for market growth is the increasing prevalence of hypertension and related cardiovascular disorders, such as heart failure and stroke. Unhealthy lifestyles characterized by sedentary behavior, obesity, and high-stress levels have led to a significant increase in the incidence of hypertension. Furthermore, the growing awareness about the importance of effective blood pressure management and the availability of affordable generic Losartan products have boosted the market's growth. However, the market also faces certain restraints, such as the presence of alternative antihypertensive medications and potential side effects associated with Losartan use. Additionally, the expiration of patents for branded Losartan products has led to increased competition from generic manufacturers, potentially impacting the market share of key players. Despite these challenges, the market presents promising opportunities for growth, including the development of novel drug delivery systems, the expansion of Losartan's therapeutic applications, and the untapped potential in emerging economies with high hypertension prevalence rates. Moreover, strategic collaborations and mergers among pharmaceutical companies are expected to drive innovation and expand market reach in the coming years.

Key features of the study

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, And Trends Analysis

4. Global Losartan Market, By Indication, 2020-2032, (USD Bn)

5. Global Losartan Market, By Strength, 2020-2032, (USD Bn)

6. Global Losartan Market, By Product Type, 2020-2032, (USD Bn)

7. Global Losartan Market, By Age Group, 2020-2032, (USD Bn)

8. Global Losartan Market, By Gender, 2020-2032, (USD Bn)

9. Global Losartan Market, By Distribution Channel, 2020-2032, (USD Bn)

10. Global Losartan Market, By Form, 2020-2032, (USD Bn)

11. Global Losartan Market, By Source, 2020-2032, (USD Bn)

12. Global Losartan Market, By Region, 2020 - 2032, Value (USD Bn)

13. Competitive Landscape

14. Analyst Recommendations

15. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â